Your browser doesn't support javascript.
loading
Can we consider soluble herpes virus entry mediator (sHVEM) as a tumor marker?
Javadzadeh, Seyed Mohammad; Tehrani, Mohsen; Keykhosravi, Mohsen; Mohammadian-Amiri, Rajeeh; Amjadi, Omolbanin; Hafezi, Nasim; Zaboli, Ehsan; Montazeriun, Mobina; Ajami, Abolghasem.
Afiliación
  • Javadzadeh SM; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Tehrani M; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Keykhosravi M; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Mohammadian-Amiri R; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Amjadi O; Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Hafezi N; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Zaboli E; Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  • Montazeriun M; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Ajami A; Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Caspian J Intern Med ; 13(4): 693-698, 2022.
Article en En | MEDLINE | ID: mdl-36420330

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Caspian J Intern Med Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Caspian J Intern Med Año: 2022 Tipo del documento: Article País de afiliación: Irán